Acquisition and processing of endobronchial ultrasound-guided transbronchial needle aspiration specimens in the era of targeted lung cancer chemotherapy

American Journal of Respiratory and Critical Care Medicine

Volumn 185, Issue 6, 2012, Pages 606-611

  Bulman, William ^a   Saqi, Anjali ^a   Powell, Charles A ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

Bronchoscopy; Cytology; EGFR; Lung cancer; Molecular testing

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE INHIBITOR;

ADVANCED CANCER; BRONCHOSCOPY; CANCER DIAGNOSIS; CANCER GROWTH; CANCER STAGING; CYTOLOGY; CYTOPATHOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ENDOBRONCHIAL ULTRASONOGRAPHY; GENE MUTATION; GENE TRANSLOCATION; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG NON SMALL CELL CANCER; LYMPH NODE; MEDIASTINOSCOPY; PRIORITY JOURNAL; REVIEW; THORACOTOMY; TRANSBRONCHIAL ASPIRATION;

ANTINEOPLASTIC AGENTS; BIOPSY, NEEDLE; BRONCHI; BRONCHOSCOPY; ENDOSONOGRAPHY; HUMANS; LUNG NEOPLASMS; REPRODUCIBILITY OF RESULTS;

EID: 84858227992     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201107-1199CI     Document Type: Review

References (60)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.
2. Halmos B, Powell CA. Update in lung cancer and oncological disorders 2010. Am J Respir Crit Care Med 2011;184:297-302.
3. Bulman WA, Powell CA. Endobronchial ultrasound-guided transbronchial needle aspiration for the diagnosis and staging of thoracic malignancy. Am J Respir Crit Care Med 2010;181:A5160.
4. Johnson DH, Fehrenbacher L, Novotny WF, Herbst RS, Nemunaitis JJ, Jablons DM, Langer CJ, DeVore RF III, Gaudreault J, Damico LA, et al. Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol 2004;22:2184-2191. (Pubitemid 41095154)
5. Sandler A, Gray R, Perry MC, Brahmer J, Schiller JH, Dowlati A, Lilenbaum R, Johnson DH. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med 2006;355: 2542-2550. (Pubitemid 44917502)
6. Scagliotti G, Brodowicz T, Shepherd FA, Zielinski C, Vansteenkiste J, Manegold C, Simms L, Fossella F, Sugarman K, Belani CP. Treatment-by-histology interaction analyses in three phase III trials show superiority of pemetrexed in nonsquamous non-small cell lung cancer. J Thorac Oncol 2011;6:64-70.
7. Langer CJ, Besse B, Gualberto A, Brambilla E, Soria JC. The evolving role of histology in the management of advanced non-small-cell lung cancer. J Clin Oncol 2010;28:5311-5320.
8. Hirsch FR, Varella-Garcia M, Cappuzzo F. Predictive value of EGFR and her2 overexpression in advanced non-small-cell lung cancer. Oncogene 2009;28:S32-S37.
9. Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW, Harris PL, Haserlat SM, Supko JG, Haluska FG, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004;350:2129-2139. (Pubitemid 38637993)
10. Paez JG, Janne PA, Lee JC, Tracy S, Greulich H, Gabriel S, Herman P, Kaye FJ, Lindeman N, Boggon TJ, et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 2004;304:1497-1500. (Pubitemid 38720929)
11. Tokumo M, Toyooka S, Kiura K, Shigematsu H, Tomii K, Aoe M, Ichimura K, Tsuda T, Yano M, Tsukuda K, et al. The relationship between epidermal growth factor receptor mutations and clinicopathologic features in non-small cell lung cancers. Clin Cancer Res 2005;11:1167-1173. (Pubitemid 40175767)
12. John T, Liu G, Tsao MS. Overview of molecular testing in non-small-cell lung cancer: mutational analysis, gene copy number, protein expression and other biomarkers of EGFR for the prediction of response to tyrosine kinase inhibitors. Oncogene 2009;28:S14-S23.
13. Maemondo M, Inoue A, Kobayashi K, Sugawara S, Oizumi S, Isobe H, Gemma A, Harada M, Yoshizawa H, Kinoshita I, et al. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR. N Engl J Med 2010;362:2380-2388.
14. Mitsudomi T, Morita S, Yatabe Y, Negoro S, Okamoto I, Tsurutani J, Seto T, Satouchi M, Tada H, Hirashima T, et al. Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (wjtog3405): an open label, randomised phase 3 trial. Lancet Oncol 2010;11:121-128.
15. Zhang Z, Stiegler AL, Boggon TJ, Kobayashi S, Halmos B. EGFR-mutated lung cancer: a paradigm of molecular oncology. Oncotarget 2010;1:497-514.
16. Keedy VL, Temin S, Somerfield MR, Beasley MB, Johnson DH, McShane LM, Milton DT, Strawn JR, Wakelee HA, Giaccone G. American Society of Clinical Oncology provisional clinical opinion: epidermal growth factor receptor (EGFR) mutation testing for patients with advanced non-small-cell lung cancer considering firstline EGFR tyrosine kinase inhibitor therapy. J Clin Oncol 2011;29: 2121-2127.
17. Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S, Fujiwara S, Watanabe H, Kurashina K, Hatanaka H, et al. Identification of the transforming eml4-alk fusion gene in non-small-cell lung cancer. Nature 2007;448:561-566. (Pubitemid 47206930)
18. Kwak EL, Bang YJ, Camidge DR, Shaw AT, Solomon B, Maki RG, Ou SH, Dezube BJ, Janne PA, Costa DB, et al. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl J Med 2010; 363:1693-1703.
19. Bunn PA Jr, Hirsch FR, Doebele RC, Camidge DR, Varella-Garcia M, Franklin W. Biomarkers are here to stay for clinical research and standard care. J Thorac Oncol 2010;5:1113-1115.
20. Gold KA, Kim ES, Lee JJ, Wistuba II, Farhangfar CJ, Hong WK. The battle to personalize lung cancer prevention through reverse migration. Cancer Prev Res (Phila Pa) 2011;4:962-972.
21. Rivera MP, Mehta AC. Initial diagnosis of lung cancer: ACCP evidencebased clinical practice guidelines (2nd edition). Chest 2007;132:131S-148S. (Pubitemid 47502804)
22. Adams K, Shah PL, Edmonds L, Lim E. Test performance of endobronchial ultrasound and transbronchial needle aspiration biopsy for mediastinal staging in patients with lung cancer: systematic review and meta-analysis. Thorax 2009;64:757-762.
23. Detterbeck FC, Jantz MA, Wallace M, Vansteenkiste J, Silvestri GA. Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007;132:202S-220S. (Pubitemid 47502808)
24. Ernst A, Anantham D, Eberhardt R, Krasnik M, Herth FJ. Diagnosis of mediastinal adenopathy-real-time endobronchial ultrasound guided needle aspiration versus mediastinoscopy. J Thorac Oncol 2008;3: 577-582. (Pubitemid 351787299)
25. Annema JT, van Meerbeeck JP, Rintoul RC, Dooms C, Deschepper E, Dekkers OM, De Leyn P, Braun J, Carroll NR, Praet M, et al. Mediastinoscopy vs endosonography for mediastinal nodal staging of lung cancer: a randomized trial. JAMA 2010;304:2245-2252.
26. Harewood GC, Pascual J, Raimondo M, Woodward T, Johnson M, McComb B, Odell J, Jamil LH, Gill KR, Wallace MB. Economic analysis of combined endoscopic and endobronchial ultrasound in the evaluation of patients with suspected non-small cell lung cancer. Lung Cancer 2010;67:366-371.
27. Kim K, Rice TW, Murthy SC, DeCamp MM, Pierce CD, Karchmer DP, Rybicki LA, Blackstone EH. Combined bronchoscopy, mediastinoscopy, and thoracotomy for lung cancer: Who benefits? J Thorac Cardiovasc Surg 2004;127:850-856. (Pubitemid 38316193)
28. Medford AR, Bennett JA, Free CM, Agrawal S. Mediastinal staging procedures in lung cancer: EBUS, TBNA and mediastinoscopy. Curr Opin Pulm Med 2009;15:334-342.
29. Defranchi SA, Edell ES, Daniels CE, Prakash UB, Swanson KL, Utz JP, Allen MS, Cassivi SD, Deschamps C, Nichols FC III, et al. Mediastinoscopy in patients with lung cancer and negative endobronchial ultrasound guided needle aspiration. Ann Thorac Surg 2010;90:1753-1757.
30. Stoll LM, Yung RC, Clark DP, Li QK. Cytology of endobronchial ultrasound-guided transbronchial needle aspiration versus conventional transbronchial needle aspiration. Cancer Cytopathol 2010;118: 278-286.
31. Nayak A, Sugrue C, Koenig S, Wasserman PG, Hoda S, Morgenstern NJ. Endobronchial ultrasound-guided transbronchial needle aspirate (EBUS-TBNA): a proposal for on-site adequacy criteria. Diagn Cytopathol (In press)
32. Alsharif M, Andrade RS, Groth SS, Stelow EB, Pambuccian SE. Endobronchial ultrasound-guided transbronchial fine-needle aspiration: the University of Minnesota experience, with emphasis on usefulness, adequacy assessment, and diagnostic difficulties. Am J Clin Pathol 2008;130:434-443.
33. Szlubowski A, Kuzdzal J, KolodziejM, Soja J, Pankowski J, Obrochta A, Kopinski P, Zielinski M. Endobronchial ultrasound-guided needle aspiration in the non-small cell lung cancer staging. Eur J Cardiothorac Surg 2009;35:332-335, discussion 335-336.
34. Gilbert S,Wilson DO, Christie NA, Pennathur A, Luketich JD, Landreneau RJ, Close JM, Schuchert MJ. Endobronchial ultrasound as a diagnostic tool in patients with mediastinal lymphadenopathy. Ann Thorac Surg 2009;88:896-900; discussion 901-892.
35. Saji J, Kurimoto N, Morita K, Nakamura M, Inoue T, Nakamura H, Miyazawa T. Comparison of 21-gauge and 22-gauge needles for endobronchial ultrasound-guided transbronchial needle aspiration of mediastinal and hilar lymph nodes. J Bronchol Intervent Pulmonol 2011;18:239-246.
36. Nakajima T, Yasufuku K, Takahashi R, Shingyoji M, Hirata T, Itami M, Matsui Y, Itakura M, Iizasa T, Kimura H. Comparison of 21-gauge and 22-gauge aspiration needle during endobronchial ultrasoundguided transbronchial needle aspiration. Respirology 2011;16:90-94.
37. Sakairi Y, Nakajima T, Yasufuku K, Ikebe D, Kageyama H, Soda M, Takeuchi K, Itami M, Iizasa T, Yoshino I, et al. Eml4-alk fusion gene assessment using metastatic lymph node samples obtained by endobronchial ultrasound-guided transbronchial needle aspiration. Clin Cancer Res 2010;16:4938-4945.
38. Nakajima T, Yasufuku K, Nakagawara A, Kimura H, Yoshino I. Multigene mutation analysis of metastatic lymph nodes in non-small cell lung cancer diagnosed by EBUS-TBNA. Chest 2011;140:1319-1324.
39. Rekhtman N, Brandt SM, Sigel CS, Friedlander MA, Riely GJ, Travis WD, Zakowski MF, Moreira AL. Suitability of thoracic cytology for new therapeutic paradigms in non-small cell lung carcinoma: high accuracy of tumor subtyping and feasibility of EGFR and kras molecular testing. J Thorac Oncol 2011;6:451-458.
40. Nakajima T, Kimura H, Takeuchi K, Soda M, Mano H, Yasufuku K, Iizasa T. Treatment of lung cancer with an ALK inhibitor after eml4-alk fusion gene detection using endobronchial ultrasound-guided transbronchial needle aspiration. J Thorac Oncol 2010;5: 2041-2043.
41. Roggli VL, Vollmer RT, Greenberg SD, McGavran MH, Spjut HJ, Yesner R. Lung cancer heterogeneity: a blinded and randomized study of 100 consecutive cases. Hum Pathol 1985;16:569-579. (Pubitemid 15049631)
42. Travis WD, Rekhtman N. Pathological diagnosis and classification of lung cancer in small biopsies and cytology: strategic management of tissue for molecular testing. Semin Respir Crit Care Med 2011;32:22-31.
43. Vazquez MF, Koizumi JH, Henschke CI, Yankelevitz DF. Reliability of cytologic diagnosis of early lung cancer. Cancer 2007;111:252-258. (Pubitemid 47301284)
44. Loukeris K, Vazquez MF, Sica G, Wagner P, Yankelevitz DF, Henschke CI, Cham MD, Saqi A. Cytological cell blocks: predictors of squamous cell carcinoma and adenocarcinoma subtypes. Diagn Cytopathol 2010;39:92-100.
45. Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, Beer DG, Powell CA, Riely GJ, Van Schil PE, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multi-disciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011;6:244-285.
46. Wallace WA, Rassl DM. Accuracy of cell typing in non-small cell lung cancer by EBUS/EUS - FNA cytology samples. Eur Respir J 2011;38:911-917.
47. Micames CG, McCrory DC, Pavey DA, Jowell PS, Gress FG. Endoscopic ultrasound-guided fine-needle aspiration for non-small cell lung cancer staging: a systematic review and metaanalysis. Chest 2007;131:539-548. (Pubitemid 46280417)
48. Layfield LJ, Bentz JS, Gopez EV. Immediate on-site interpretation of fine-needle aspiration smears: a cost and compensation analysis. Cancer 2001;93:319-322. (Pubitemid 32995215)
49. Wallace WA, Monaghan HM, Salter DM, Gibbons MA, Skwarski KM. Endobronchial ultrasound-guided fine-needle aspiration and liquid-based thin-layer cytology. J Clin Pathol 2007;60:388-391. (Pubitemid 46596557)
50. Nasuti JF, Gupta PK, Baloch ZW. Diagnostic value and costeffectiveness of on-site evaluation of fine-needle aspiration specimens: review of 5,688 cases. Diagn Cytopathol 2002;27:1-4. (Pubitemid 34721605)
51. Nakajima T, Yasufuku K. How I do it: optimal methodology for multidirectional analysis of endobronchial ultrasound-guided transbronchial needle aspiration samples. J Thorac Oncol 2011;6:203-206.
52. Giri D, Vazquez MF. "Pick and smear" tissue concentration technique for bloody aspirates. Acta Cytol 2001;45:889-890. (Pubitemid 32895963)
53. Billah S, Stewart J, Staerkel G, Chen S, Gong Y, Guo M. EGFR and kras mutations in lung carcinoma: molecular testing by using cytology specimens. Cancer Cytopathol 2011;119:111-117.
54. Natu S, Hoffman J, Siddiqui M, Hobday C, Shrimankar J, Harrison R. The role of endobronchial ultrasound guided transbronchial needle aspiration cytology in the investigation of mediastinal lymphadenopathy and masses. The North Tees experience. J Clin Pathol 2010;63:445-451.
55. Kung IT, Yuen RW, Chan JK. Optimal formalin fixation and processing schedule of cell blocks from fine needle aspirates. Pathology 1989;21:143-145. (Pubitemid 20036640)
56. Bulman WA, Saqi A, Turk A, Maxfield R, Powell CA. Endobronchial ultrasound-guided transbronchial needle aspiration for diagnosis and staging of thoracic malignancy: sensitivity and optimization of the cytologic specimen. Presented at the American Thoracic Society 2010 International Conference. May 14-19, 2010, New Orleans, LA.
57. Travis WD, Rekhtman N, Riley GJ, Geisinger KR, Asamura H, Brambilla E, Garg K, Hirsch FR, Noguchi M, Powell CA, et al. Pathologic diagnosis of advanced lung cancer based on small biopsies and cytology: a paradigm shift. J Thorac Oncol 2010;5:411-414.
58. Lozano MD, Zulueta JJ, Echeveste JI, Gurpide A, Seijo LM, Martin- Algarra S, Del Barrio A, Pio R, Idoate MA, Labiano T, et al. Assessment of epidermal growth factor receptor and k-ras mutation status in cytological stained smears of non-small cell lung cancer patients: correlation with clinical outcomes. Oncologist 2011;16:877-885.
59. Schuurbiers OC, Looijen-Salamon MG, Ligtenberg MJ, van der Heijden HF. A brief retrospective report on the feasibility of epidermal growth factor receptor and kras mutation analysis in transesophageal ultrasound- and endobronchial ultrasound-guided fine needle cytological aspirates. J Thorac Oncol 2010;5:1664-1667.
60. Sequist LV, Waltman BA, Dias-Santagata D, Digumarthy S, Turke AB, Fidias P, Bergethon K, Shaw AT, Gettinger S, Cosper AK, et al. Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors. Science Translational Medicine 2011;3:75ra26.